WHO ICTRP trial
A phase II study evaluating the efficacy and safety of the farnesyltransferase…
EUCTR2006-007066-11-FR · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2006-007066-11-FR |
|---|---|
| Public title | A phase II study evaluating the efficacy and safety of the farnesyltransferase inhibitor ZARNESTRA® (R115777, tipifarnib) in patients with relapsed , refractory or progressive mantle cell lymphoma not appropriate for autologous bone marrow transplantation - Zarnestra® (tipifarnib) for oral administration |
| Scientific title | A phase II study evaluating the efficacy and safety of the farnesyltransferase inhibitor ZARNESTRA® (R115777, tipifarnib) in patients with relapsed , refractory or progressive mantle cell lymphoma not appropriate for autologous bone marrow transplantation - Zarnestra® (tipifarnib) for oral… |
| Primary sponsor | GELA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | France |
| Conditions | adult patients with relapsed , refractory or progressive mantle cell lymphoma not appropriate for autologous bone marrow transplantation MedDRA version: 9.1 Level: LLT Classification code 10026800 Term: Mantle cell lymphoma recurrent MedDRA… |
| Interventions | Product Name: zarnestra Product Code: R115777 Pharmaceutical Form: Tablet INN or Proposed INN: TIPIFARNIB CAS Number: 192185721 Current Sponsor code: R115777 Other descriptive name: TIPIFARNIB Concentration unit: mg milligram(s)… |
| Registration date | Jun 4, 2007 |
| Secondary IDs | MCL06-1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: